CSIMarket
 


Biophytis Sa  (BPTS)
Other Ticker:  
 

Cumulative Biophytis Sa's Leverage Ratio for Trailing Twelve Months Period

BPTS's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

BPTS Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2021)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter

Y / Y Equity Growth - - - - -
Y / Y Total Liabilities Growth - - - - -
Leverage Ratio for Trailing Twelve Months Period 5.36 5.36 5.36 5.36 -
Total Ranking # 4186 # # # #
Seq. Equity Growth 0 % 0 % 0 % - -
Seq. Total Liabilities Growth 0 % 0 % 0 % - -


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2021
On the trailing twelve months basis Due to debt repayement of 0% Biophytis Sa has not changed Leverage Ratio for Trailing Twelve Months Period in the IV. Quarter to 5.36, a new company low.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 518 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Biophytis Sa. While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are BPTS's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 519
Sector # 1036
S&P 500 # 4116


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
5.36 5.36 5.36
(Dec 31 2021)  




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2021, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Ptc Therapeutics inc   14.18 
Intelgenx Technologies Corp   13.22 
Silence Therapeutics Plc  12.63 
Amneal Pharmaceuticals Inc   9.67 
Nls Pharmaceutics Ltd   9.63 
Morphosys Ag  9.44 
Abbvie inc   9.19 
Aptevo Therapeutics Inc   8.96 
Acer Therapeutics Inc   8.87 
Conduit Pharmaceuticals Inc   8.59 
Kadmon holdings inc   7.74 
Epizyme Inc.  7.73 
Apellis Pharmaceuticals Inc   7.44 
Tricida Inc   7.24 
Axim Biotechnologies Inc   6.83 
Clene Inc   6.44 
Xilio Therapeutics inc   5.47 
Biophytis Sa  5.36 
Dicerna Pharmaceuticals Inc   5.22 
Dynavax Technologies Corporation  5.02 
Journey Medical Corporation  4.71 
Societal Cdmo Inc   4.21 
Eli Lilly And Company  4.20 
Sunwin Stevia International Inc.  4.13 
Lianbio  3.81 
Avid Bioservices Inc   3.75 
Harrow Inc   3.66 
Alnylam Pharmaceuticals Inc   3.57 
Maravai Lifesciences Holdings Inc   3.51 
Cytomx Therapeutics Inc   3.45 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com